本文研究喷雾法吸入胰岛素对２型糖尿病患者的临床效用和安全性。方法 患者年龄３５~６５岁,体重为理想体重的１００%~１７５%,每天定期注射胰岛素２~３次达１个月以上,ＨｂＡ１ｃ水平０．０７~０．１２(７．０%~１１．９%),Ｃ－肽浓度≥０．２ｐｍｏｌ/ｍＬ,胸片和肺功能试验均正常。本研究采用随机开放标记,包括基线进入期４周(继续每天注射胰岛素２~３次)和治疗期１２周,在基线期末,患者首先 This article studies the clinical efficacy and safety of nebulized insulin inhalation for type 2 diabetes mellitus. Methods The patients were 35-65 years old and weighed 100% -175% of the ideal body weight. The patients were injected with insulin 2-3 times a day for more than 1 month. The level of HbA1c was 0.07-0.12 (7.0% -11%). 9%), C-peptide concentration ≥ 0.2 pmol / mL, chest X-ray and pulmonary function tests were normal. This study randomized open-label, including the baseline entry period of 4 weeks (continue to inject insulin 2 to 3 times daily) and the treatment period of 12 weeks, at the end of the baseline, patients first